HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration.

Abstract
The neuroprotective effects of progesterone after ischemic stroke have been established, but the role of progesterone in promoting cerebrovascular repair remains under-explored. Male Sprague-Dawley rats underwent transient middle cerebral artery occlusion (tMCAO) for 90 min followed by reperfusion for 3 days. Progesterone (8 mg/kg/day) was administered intraperitoneally at 1h after initial occlusion followed by subcutaneous injections at 6, 24 and 48 h post-occlusion. Rats were euthanized after 72 h and brain endothelial cell density and macrophage infiltration were evaluated within the cerebral cortex. We also assessed progesterone's ability to induce macrophage migration toward hypoxic/reoxygenated cultured endothelial cells. We found that progesterone treatment post-tMCAO protects ischemic endothelial cells from macrophage infiltration. We further demonstrate that infiltration of monocytes/macrophages can be induced by potent chemotactic factors such as monocyte chemoattractant protein-1 (MCP-1) and the chemokine ligand 1 (CXCL1), secreted by hypoxic/reoxygenated endothelial cells. Progesterone blunts secretion of MCP-1 and CXCL1 from endothelial cells after hypoxia/reoxygenation injury and decreases leukocyte infiltration. The treatment protects ischemic endothelial cells from macrophage infiltration and thus preserves vascularization after ischemic injury.
AuthorsEbony Washington Remus, Iqbal Sayeed, Soonmi Won, Alicia N Lyle, Donald G Stein
JournalExperimental neurology (Exp Neurol) Vol. 271 Pg. 401-8 (Sep 2015) ISSN: 1090-2430 [Electronic] United States
PMID26188381 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 antigen, human
  • Ccl2 protein, rat
  • Chemokine CCL2
  • Chemokine CXCL1
  • Cxcl1 protein, rat
  • Cytokines
  • Ki-67 Antigen
  • Progestins
  • Progesterone
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, Myelomonocytic (metabolism)
  • Cell Hypoxia (drug effects)
  • Cell Movement (drug effects)
  • Cells, Cultured
  • Chemokine CCL2 (metabolism)
  • Chemokine CXCL1 (metabolism)
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Endothelial Cells (drug effects)
  • Gene Expression Regulation (drug effects)
  • Infarction, Middle Cerebral Artery (drug therapy, metabolism, pathology)
  • Ki-67 Antigen (metabolism)
  • Macrophages (drug effects)
  • Male
  • Progesterone (therapeutic use)
  • Progestins (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: